Annual Operating Profit
$166.96 M
+$133.64 M+401.10%
December 31, 2023
Summary
- As of February 7, 2025, COLL annual operating income is $166.96 million, with the most recent change of +$133.64 million (+401.10%) on December 31, 2023.
- During the last 3 years, COLL annual operating profit has risen by +$110.73 million (+196.91%).
- COLL annual operating profit is now at all-time high.
Performance
COLL Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
$34.84 M
-$12.63 M-26.61%
September 30, 2024
Summary
- As of February 7, 2025, COLL quarterly operating income is $34.84 million, with the most recent change of -$12.63 million (-26.61%) on September 30, 2024.
- Over the past year, COLL quarterly operating profit has dropped by -$10.17 million (-22.60%).
- COLL quarterly operating profit is now -43.52% below its all-time high of $61.69 million, reached on December 31, 2023.
Performance
COLL Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
$193.47 M
-$10.17 M-5.00%
September 30, 2024
Summary
- As of February 7, 2025, COLL TTM operating income is $193.47 million, with the most recent change of -$10.17 million (-5.00%) on September 30, 2024.
- Over the past year, COLL TTM operating profit has increased by +$76.44 million (+65.32%).
- COLL TTM operating profit is now -5.00% below its all-time high of $203.65 million, reached on June 30, 2024.
Performance
COLL TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
COLL Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +401.1% | -22.6% | +65.3% |
| 3 y3 years | +196.9% | -22.6% | +65.3% |
| 5 y5 years | +907.2% | -22.6% | +65.3% |
COLL Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +651.9% | -43.5% | +217.9% | -5.0% | +1453.0% |
| 5 y | 5-year | at high | +803.0% | -43.5% | +217.9% | -5.0% | +914.7% |
| alltime | all time | at high | +277.5% | -43.5% | +217.9% | -5.0% | +290.3% |
Collegium Pharmaceutical Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $34.84 M(-26.6%) | $193.47 M(-5.0%) |
| Jun 2024 | - | $47.47 M(-4.0%) | $203.65 M(+6.2%) |
| Mar 2024 | - | $49.47 M(-19.8%) | $191.81 M(+14.9%) |
| Dec 2023 | $166.96 M(+401.1%) | $61.69 M(+37.0%) | $166.96 M(+42.7%) |
| Sep 2023 | - | $45.01 M(+26.3%) | $117.03 M(+26.5%) |
| Jun 2023 | - | $35.63 M(+44.7%) | $92.48 M(+36.1%) |
| Mar 2023 | - | $24.63 M(+109.5%) | $67.96 M(+104.0%) |
| Dec 2022 | $33.32 M(+50.0%) | $11.76 M(-42.6%) | $33.32 M(-517.4%) |
| Sep 2022 | - | $20.47 M(+84.2%) | -$7.98 M(-44.2%) |
| Jun 2022 | - | $11.11 M(-210.9%) | -$14.30 M(+58.9%) |
| Mar 2022 | - | -$10.02 M(-66.1%) | -$9.00 M(-140.5%) |
| Dec 2021 | $22.21 M(-60.5%) | -$29.54 M(-308.8%) | $22.21 M(-66.7%) |
| Sep 2021 | - | $14.15 M(-13.8%) | $66.75 M(-7.6%) |
| Jun 2021 | - | $16.41 M(-22.6%) | $72.22 M(-0.2%) |
| Mar 2021 | - | $21.19 M(+41.3%) | $72.36 M(+28.7%) |
| Dec 2020 | $56.23 M(-336.8%) | $15.00 M(-23.6%) | $56.23 M(+44.7%) |
| Sep 2020 | - | $19.63 M(+18.6%) | $38.86 M(+202.2%) |
| Jun 2020 | - | $16.55 M(+227.0%) | $12.86 M(-247.9%) |
| Mar 2020 | - | $5.06 M(-313.3%) | -$8.70 M(-63.4%) |
| Dec 2019 | -$23.75 M | -$2.37 M(-62.8%) | -$23.75 M(+128.9%) |
| Sep 2019 | - | -$6.38 M(+27.3%) | -$10.37 M(-31.7%) |
| Jun 2019 | - | -$5.01 M(-49.9%) | -$15.19 M(-13.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$9.99 M(-190.8%) | -$17.47 M(-15.5%) |
| Dec 2018 | -$20.68 M(-72.6%) | $11.00 M(-198.3%) | -$20.68 M(-58.0%) |
| Sep 2018 | - | -$11.19 M(+53.4%) | -$49.27 M(-4.4%) |
| Jun 2018 | - | -$7.29 M(-44.8%) | -$51.51 M(-21.3%) |
| Mar 2018 | - | -$13.21 M(-24.9%) | -$65.48 M(-13.2%) |
| Dec 2017 | -$75.45 M(-19.8%) | -$17.58 M(+30.9%) | -$75.45 M(-11.7%) |
| Sep 2017 | - | -$13.43 M(-36.8%) | -$85.44 M(-13.2%) |
| Jun 2017 | - | -$21.26 M(-8.3%) | -$98.45 M(-3.2%) |
| Mar 2017 | - | -$23.18 M(-16.0%) | -$101.67 M(+8.1%) |
| Dec 2016 | -$94.08 M(+249.7%) | -$27.58 M(+4.3%) | -$94.08 M(+23.9%) |
| Sep 2016 | - | -$26.44 M(+8.0%) | -$75.94 M(+29.2%) |
| Jun 2016 | - | -$24.47 M(+57.0%) | -$58.76 M(+51.2%) |
| Mar 2016 | - | -$15.59 M(+65.2%) | -$38.86 M(+44.4%) |
| Dec 2015 | -$26.91 M(+52.3%) | -$9.44 M(+1.8%) | -$26.91 M(+29.4%) |
| Sep 2015 | - | -$9.27 M(+102.5%) | -$20.80 M(+15.3%) |
| Jun 2015 | - | -$4.58 M(+26.0%) | -$18.04 M(+2.8%) |
| Mar 2015 | - | -$3.63 M(+9.1%) | -$17.55 M(-0.6%) |
| Dec 2014 | -$17.66 M(+10.1%) | -$3.33 M(-48.9%) | -$17.66 M(+23.2%) |
| Sep 2014 | - | -$6.50 M(+59.1%) | -$14.34 M(+83.1%) |
| Jun 2014 | - | -$4.09 M(+9.2%) | -$7.83 M(+109.2%) |
| Mar 2014 | - | -$3.74 M | -$3.74 M |
| Dec 2013 | -$16.04 M | - | - |
FAQ
- What is Collegium Pharmaceutical annual operating income?
- What is the all time high annual operating profit for Collegium Pharmaceutical?
- What is Collegium Pharmaceutical annual operating profit year-on-year change?
- What is Collegium Pharmaceutical quarterly operating income?
- What is the all time high quarterly operating profit for Collegium Pharmaceutical?
- What is Collegium Pharmaceutical quarterly operating profit year-on-year change?
- What is Collegium Pharmaceutical TTM operating income?
- What is the all time high TTM operating profit for Collegium Pharmaceutical?
- What is Collegium Pharmaceutical TTM operating profit year-on-year change?
What is Collegium Pharmaceutical annual operating income?
The current annual operating profit of COLL is $166.96 M
What is the all time high annual operating profit for Collegium Pharmaceutical?
Collegium Pharmaceutical all-time high annual operating income is $166.96 M
What is Collegium Pharmaceutical annual operating profit year-on-year change?
Over the past year, COLL annual operating income has changed by +$133.64 M (+401.10%)
What is Collegium Pharmaceutical quarterly operating income?
The current quarterly operating profit of COLL is $34.84 M
What is the all time high quarterly operating profit for Collegium Pharmaceutical?
Collegium Pharmaceutical all-time high quarterly operating income is $61.69 M
What is Collegium Pharmaceutical quarterly operating profit year-on-year change?
Over the past year, COLL quarterly operating income has changed by -$10.17 M (-22.60%)
What is Collegium Pharmaceutical TTM operating income?
The current TTM operating profit of COLL is $193.47 M
What is the all time high TTM operating profit for Collegium Pharmaceutical?
Collegium Pharmaceutical all-time high TTM operating income is $203.65 M
What is Collegium Pharmaceutical TTM operating profit year-on-year change?
Over the past year, COLL TTM operating income has changed by +$76.44 M (+65.32%)